Document Detail


Atypical hemolytic uremic syndrome associated with mutations in complement regulator genes.
MedLine Citation:
PMID:  20865641     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
In the last 10 years the knowledge of the pathophysiology of atypical hemolytic uremic syndrome (aHUS) has substantially increased. Nevertheless, aHUS remains a severe disorder, in which early recognition of symptoms remains a key issue. The landmark discovery of genetic abnormalities in complement regulatory genes in most patients gave us new insights into the influence of each abnormality on the disease outcome and opened new perspectives for patient management. This allows a potentially more tailored approach in treating aHUS patients.
Authors:
Moglie Le Quintrec; Lubka Roumenina; Marina Noris; Véronique Frémeaux-Bacchi
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-09-23
Journal Detail:
Title:  Seminars in thrombosis and hemostasis     Volume:  36     ISSN:  1098-9064     ISO Abbreviation:  Semin. Thromb. Hemost.     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-09-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0431155     Medline TA:  Semin Thromb Hemost     Country:  United States    
Other Details:
Languages:  eng     Pagination:  641-52     Citation Subset:  IM    
Copyright Information:
© Thieme Medical Publishers.
Affiliation:
Service de Néphrologie, Hôpital Foch, 40 rue Worth, Suresnes, Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Anti-factor H autoantibody-associated hemolytic uremic syndrome: review of literature of the autoimm...
Next Document:  Transplantation in atypical hemolytic uremic syndrome.